ATE327983T1 - Thia- und oxazole und deren verwendung als ppars- aktivatoren - Google Patents

Thia- und oxazole und deren verwendung als ppars- aktivatoren

Info

Publication number
ATE327983T1
ATE327983T1 AT01990571T AT01990571T ATE327983T1 AT E327983 T1 ATE327983 T1 AT E327983T1 AT 01990571 T AT01990571 T AT 01990571T AT 01990571 T AT01990571 T AT 01990571T AT E327983 T1 ATE327983 T1 AT E327983T1
Authority
AT
Austria
Prior art keywords
sup
sub
alkyl
independently
och
Prior art date
Application number
AT01990571T
Other languages
English (en)
Inventor
Paul John Beswick
Vipulkumar Patel
Michael L Sierra
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE327983T1 publication Critical patent/ATE327983T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01990571T 2000-12-20 2001-12-18 Thia- und oxazole und deren verwendung als ppars- aktivatoren ATE327983T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0031109.2A GB0031109D0 (en) 2000-12-20 2000-12-20 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE327983T1 true ATE327983T1 (de) 2006-06-15

Family

ID=9905493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01990571T ATE327983T1 (de) 2000-12-20 2001-12-18 Thia- und oxazole und deren verwendung als ppars- aktivatoren

Country Status (8)

Country Link
US (1) US7196107B2 (de)
EP (1) EP1343772B1 (de)
AT (1) ATE327983T1 (de)
AU (1) AU2002229669A1 (de)
DE (1) DE60120217T2 (de)
ES (1) ES2265448T3 (de)
GB (1) GB0031109D0 (de)
WO (1) WO2002050048A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302397A3 (en) 2000-05-26 2007-02-28 Nippon Shinyaku Co Ltd Heterocyclic compounds and pharmaceutical compositions containing them
US20040072838A1 (en) 2000-12-20 2004-04-15 Pierette Banker Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
US7265137B2 (en) * 2001-08-10 2007-09-04 Nippon Chemiphar Co., Ltd. Activator of peroxisome proliferator-activated re-ceptor δ
PL210475B1 (pl) 2001-08-13 2012-01-31 Janssen Pharmaceutica Nv Pochodna 2,4,5-tripodstawionego tiazolilu, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna i sposób jej wytwarzania
MXPA04002330A (es) 2001-09-14 2005-04-08 Japan Tobacco Inc Compuestos biarilo ligados.
WO2003033493A1 (fr) * 2001-10-12 2003-04-24 Nippon Chemiphar Co.,Ltd. Activateur du recepteur $g(d) active par le proliferateur de peroxisome
US6833380B2 (en) 2002-03-07 2004-12-21 Warner-Lambert Company, Llc Compounds that modulate PPAR activity and methods of preparation
US6875780B2 (en) 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
DE10251513A1 (de) * 2002-11-04 2004-05-19 Basf Ag Übergangsmetallkatalysatoren für (Co)Polymerisation von olefinischen Monomeren
US7244763B2 (en) 2003-04-17 2007-07-17 Warner Lambert Company Llc Compounds that modulate PPAR activity and methods of preparation
WO2005009104A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
EP1745014B1 (de) 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Neue verbindungen, deren herstellung und verwendung
ES2449618T3 (es) 2005-06-30 2014-03-20 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de PPAR-delta
AU2006327003B2 (en) 2005-12-22 2011-10-06 Vtv Therapeutics Llc Phenoxy acetic acids as PPAR delta activators
US7943612B2 (en) 2006-03-09 2011-05-17 High Point Pharmaceuticals, Llc Compounds that modulate PPAR activity, their preparation and use
EP2014652B1 (de) 2006-04-18 2014-08-06 Nippon Chemiphar Co., Ltd. Aktivierungsmittel für den peroxisomproliferatoraktivierten rezeptor
WO2007122970A1 (ja) * 2006-04-20 2007-11-01 Osaka University 核内受容体に結合するリガンド
FR2910893A1 (fr) * 2006-12-29 2008-07-04 Genfit Sa Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazolyl)-phenyl-propan-1-one substitues, preparations et utilisations.
RU2501794C2 (ru) 2008-04-15 2013-12-20 Ниппон Кемифар Ко., Лтд. Активирующий агент для рецептора, активируемого стимулирующими рост пероксисом агентами
CA2740874C (en) 2008-10-17 2018-02-27 Metabolex, Inc. Use of ppar.gamma.agonists to reduce small dense ldl particles
RU2012109545A (ru) * 2009-08-14 2013-09-20 Серенис Терапьютикс С.А. Использование лигандов ppar дельта для лечения или предотвращения воспалений или заболеваний, связанных с метаболизмом/выработкой энергии
US9487493B2 (en) 2013-09-09 2016-11-08 Vtv Therapeutics Llc Use of a PPAR-delta agonist for treating muscle atrophy
CN109897013B (zh) * 2019-03-31 2023-04-07 无锡科华生物科技有限公司 一种选择性PPARδ激动剂GW501516的制备方法
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000068151A (ko) * 1996-08-19 2000-11-25 미즈노 마사루 프로피온산 유도체 및 그의 용도
GB9914977D0 (en) 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
ES2204684T3 (es) * 1999-08-27 2004-05-01 Eli Lilly And Company Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
WO2002014291A1 (en) * 2000-08-11 2002-02-21 Nippon Chemiphar Co.,Ltd. PPARδ ACTIVATORS
GB0031103D0 (en) 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
GB0031107D0 (en) 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DE60120217T2 (de) 2007-03-29
GB0031109D0 (en) 2001-01-31
ES2265448T3 (es) 2007-02-16
DE60120217D1 (de) 2006-07-06
EP1343772B1 (de) 2006-05-31
AU2002229669A1 (en) 2002-07-01
WO2002050048A1 (en) 2002-06-27
US20040102493A1 (en) 2004-05-27
EP1343772A1 (de) 2003-09-17
US7196107B2 (en) 2007-03-27

Similar Documents

Publication Publication Date Title
ATE327983T1 (de) Thia- und oxazole und deren verwendung als ppars- aktivatoren
PE43098A1 (es) Derivados del acido 4-hidroxi fenilalcanoico
DE69327944D1 (de) Thiazolidindione-Derivate, ihre Herstellung und Verwendung
HUP0301655A2 (hu) Peroxisom proliferátor aktivált receptor alfa agonista triazolszármazékok és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NO20035367D0 (no) Modulatorer av peroksisomproliferatoraktiverte reseptorer (PPAR)
MY104958A (en) Thiazolidinedione hypoglycemic agents.
NZ312161A (en) The use of human Cb2 receptor agonists for preparing immunomodulating compounds
PE20011010A1 (es) Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
ATE369855T1 (de) Modulatoren von peroxisome proliferator- aktivierten rezeptoren
HUP0402236A2 (hu) Heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2006014262A3 (en) Indoles having anti-diabetic activity
ATE382043T1 (de) Sulfonamid-derivate als ppar-modulatoren
AU562113B2 (en) Benzoxazolinones
NO20063720L (no) Antidiabetiske oksazolidiendioner og tiazolidiendioner
WO2003048130A3 (en) Peroxisome proliferator activated receptor agonists
ATE173729T1 (de) Blutzuckersenkende di-oxadiazolderivate
DE69432542D1 (de) Tetraderivate, ihre Herstellung und Verwendung
FI901659A0 (fi) 3,5-dihydroxi-6,8-nonadiensyror och derivat som kolesterol saenkande aemnen.
AR034051A1 (es) Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
EA200200470A1 (ru) Новые производные тиазолидиндиона в качестве противодиабетических средств
JP2004532267A5 (de)
ATE206050T1 (de) Okulares hypotensium
RS50790B (sr) Korišćenje derivata piridoindolona za spravljanje lekova
DE69504349D1 (de) (3,4-dioxocyclobuten-1-yl)chromen-, inden-, und dehydronaphthalenon-derivate mit einer entspannenden wirkung auf glatte muskeln
FI871984A0 (fi) 3-aminodihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties